See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Gräsbeck Ralph. The evolution of the reference value concept. Clinical Chemistry and Laboratory Medicine (CCLM). Vol. 42(7)2004. Walter de Gruyter GmbH. [Cross Ref]
Whyte Martin Brunel, Kelly Philip. The normal range: it is not normal and it is not a range. Postgraduate Medical Journal. Vol. 94(1117):613–616. 2018. Oxford University Press (OUP). [Cross Ref]
Dutkiewicz Tomasz. THE NORMAL RANGE AND THE DECISION INTERVAL. Pomeranian Journal of Life Sciences. Vol. 60(1)2016. Pomorski Uniwersytet Medyczny w Szczecinie. [Cross Ref]
Adler-Milstein Julia, Chen Jonathan H., Dhaliwal Gurpreet. Next-Generation Artificial Intelligence for Diagnosis. JAMA. Vol. 326(24)2021. American Medical Association (AMA). [Cross Ref]
Yang Daniel, Fineberg Harvey V., Cosby Karen. Diagnostic Excellence. JAMA. Vol. 326(19)2021. American Medical Association (AMA). [Cross Ref]
Watari Takashi, Schiff Gordon D.. Diagnostic excellence in primary care. Journal of General and Family Medicine. 2023. Wiley. [Cross Ref]
Agha Leila, Skinner Jonathan, Chan David. Improving Efficiency in Medical Diagnosis. JAMA. Vol. 327(22)2022. American Medical Association (AMA). [Cross Ref]
Berwick Donald M.. Diagnostic Excellence Through the Lens of Patient-Centeredness. JAMA. Vol. 326(21)2021. American Medical Association (AMA). [Cross Ref]
Kocher Bob, Emanuel Ezekiel J.. Aligning Incentives for Improving Diagnostic Excellence. JAMA. Vol. 327(16)2022. American Medical Association (AMA). [Cross Ref]
Dahabreh Issa J., Kazi Dhruv S.. Toward Personalizing Care. JAMA. Vol. 329(13)2023. American Medical Association (AMA). [Cross Ref]
Lee Andrew, Mavaddat Nasim, Wilcox Amber N., Cunningham Alex P., Carver Tim, Hartley Simon, Babb de Villiers Chantal, Izquierdo Angel, Simard Jacques, Schmidt Marjanka K., Walter Fiona M., Chatterjee Nilanjan, Garcia-Closas Montserrat, Tischkowitz Marc, Pharoah Paul, Easton Douglas F., Antoniou Antonis C.. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genetics in Medicine. Vol. 21(8):1708–1718. 2019. Elsevier BV. [Cross Ref]
Antoniou A C, Cunningham A P, Peto J, Evans D G, Lalloo F, Narod S A, Risch H A, Eyfjord J E, Hopper J L, Southey M C, Olsson H, Johannsson O, Borg A, Passini B, Radice P, Manoukian S, Eccles D M, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi O-P, Eerola H, Nevanlinna H, Pharoah P D P, Easton D F. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. British Journal of Cancer. Vol. 98(8):1457–1466. 2008. Springer Science and Business Media LLC. [Cross Ref]
Nashef S.A.M., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R.. European system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardio-Thoracic Surgery. Vol. 16(1):9–13. 1999. Oxford University Press (OUP). [Cross Ref]
Nashef S. A. M., Roques F., Sharples L. D., Nilsson J., Smith C., Goldstone A. R., Lockowandt U.. EuroSCORE II. European Journal of Cardio-Thoracic Surgery. Vol. 41(4):734–745. 2012. Oxford University Press (OUP). [Cross Ref]
Noorani Alia, Hippelainen Mikko, Nashef Samer A. M.. Time Until Treatment Equipoise. JAMA Surgery. Vol. 149(2)2014. American Medical Association (AMA). [Cross Ref]